In this issue:
Drug survival of biologics and non-biologics in palmoplantar psoriasis
Discontinuation of anti-TNF treatment for blood test abnormalities
Allergic contact dermatitis patch test results on dupilumab
Multi-failure psoriasis patients
Systemic and biological therapy in moderate-to-severe psoriasis
Impact of dupilumab on work productivity in atopic dermatitis
Response to biologic therapies in moderate-to-severe plaque psoriasis
Ixekizumab and guselkumab responses by body region in plaque psoriasis
Baricitinib in atopic dermatitis
Please login below to download this issue (PDF)